I learned about sickle cell disease from Lubert Stryer's biochemistry textbook back in the last century, and haven't thought much about it since. Surely, if a textbook on my shelf has a whole chapter about the molecular mechanisms producing this disease, there must be a cure and people affected must get the help they need?
Well, reading Kevin Davies's excellent book "Curved Air" for review (to be published in a few months time), I found out that the disease has been neglected for a century after its first description in 1910. Only recently has it moved to the cutting edge of biomedical research, thanks to the overwhelming success of the first first ever FDA-approved CRISPR-Cas gene editing therapy. While it doesn't quite repair the original problem, it does the second best thing and supplies the people affected with enough healthy hemoglobin for a perfectly normal life.
Inspired by this story, I also rounded up some recent clinical trials related to SCD and made a feature out of it, which is out now:
Overcoming sickle cell disease
Current Biology Volume 36, Issue 212, 16 November 2026, Pages R1255--R1257
Restricted access to full text and PDF download
Magic link for free access
(first seven weeks only)
(Unfortunately, this year's features will no longer become open access one year after publication - do contact me if you would like a PDF and the magic link has expired.)
See also my new Mastodon thread where I will highlight all this year's CB features.
Coloured scanning electron microscope image of normal blood cells next to a sickle blood cell. (Photo: OpenStax College/Wikimedia Commons (CC BY 3.0).)
My mastodon posts are also mirrored on Bluesky.
Last year's thread is here .

No comments:
Post a Comment